These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10339653)

  • 61. Age related association of Her-2/neu with prognostic markers in female breast carcinoma.
    Sharif MA; Mamoon N; Mushtaq S; Khadim MT
    J Coll Physicians Surg Pak; 2010 Sep; 20(9):590-4. PubMed ID: 20810050
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35.
    Shavers VL; Harlan LC; Stevens JL
    Cancer; 2003 Jan; 97(1):134-47. PubMed ID: 12491515
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognosis among African-American women and white women with lymph node negative breast carcinoma: findings from two randomized clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP).
    Dignam JJ; Redmond CK; Fisher B; Costantino JP; Edwards BK
    Cancer; 1997 Jul; 80(1):80-90. PubMed ID: 9210712
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic significance of HER-2/neu and survival of breast cancer patients attending a specialized breast clinic in Kolkata, Eastern India.
    Jana D; Mandal S; Mukhopadhyay M; Mitra D; Mukhopadhyay SK; Sarkar DK
    Asian Pac J Cancer Prev; 2012; 13(8):3851-5. PubMed ID: 23098482
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
    Parise CA; Bauer KR; Brown MM; Caggiano V
    Breast J; 2009; 15(6):593-602. PubMed ID: 19764994
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype.
    Hausauer AK; Keegan TH; Chang ET; Clarke CA
    Breast Cancer Res; 2007; 9(6):R90. PubMed ID: 18162138
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.
    Ariga R; Zarif A; Korasick J; Reddy V; Siziopikou K; Gattuso P
    Breast J; 2005; 11(4):278-80. PubMed ID: 15982396
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
    Margalit DN; Sreedhara M; Chen YH; Catalano PJ; Nguyen PL; Golshan M; Overmoyer BA; Harris JR; Brock JE
    Ann Surg Oncol; 2013 Mar; 20(3):811-8. PubMed ID: 22956068
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women.
    Vadgama JV; Wu Y; Datta G; Khan H; Chillar R
    Oncology; 1999 Nov; 57(4):330-40. PubMed ID: 10575321
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Her-2/neu status: a neglected marker of prognostication and management of breast cancer patients in India.
    Zubeda S; Kaipa PR; Shaik NA; Mohiuddin MK; Vaidya S; Pavani B; Srinivasulu M; Latha MM; Hasan Q
    Asian Pac J Cancer Prev; 2013; 14(4):2231-5. PubMed ID: 23725118
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
    Carey LA; Perou CM; Livasy CA; Dressler LG; Cowan D; Conway K; Karaca G; Troester MA; Tse CK; Edmiston S; Deming SL; Geradts J; Cheang MC; Nielsen TO; Moorman PG; Earp HS; Millikan RC
    JAMA; 2006 Jun; 295(21):2492-502. PubMed ID: 16757721
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer.
    Spizzo G; Obrist P; Ensinger C; Theurl I; Dünser M; Ramoni A; Gunsilius E; Eibl G; Mikuz G; Gastl G
    Int J Cancer; 2002 Apr; 98(6):883-8. PubMed ID: 11948467
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of estrogen receptors, progesterone receptors and HER-2/neu expression between primary and metastatic breast carcinoma.
    Azam M; Qureshi A; Mansoor S
    J Pak Med Assoc; 2009 Nov; 59(11):736-40. PubMed ID: 20361669
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Serum her-2/neu level and related factors in patients with breast cancer].
    Yuan P; Xu BH; Zhang C; Qi J
    Zhonghua Zhong Liu Za Zhi; 2003 Nov; 25(6):573-4. PubMed ID: 14690565
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer.
    Huang HJ; Neven P; Drijkoningen M; Paridaens R; Wildiers H; Van Limbergen E; Berteloot P; Amant F; Vergote I; Christiaens MR
    J Clin Pathol; 2005 Jun; 58(6):611-6. PubMed ID: 15917412
    [TBL] [Abstract][Full Text] [Related]  

  • 76. HER-2, ER, PR status concordance in primary breast cancer and corresponding metastatic lesion in lymph node in Chinese women.
    Li MH; Hou CL; Wang C; Sun AJ
    Pathol Res Pract; 2016 Apr; 212(4):252-7. PubMed ID: 26899763
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Frequency Of Hormone Receptors And Her-2/Neu Receptor Positivity In Different Histology In Breast Cancer Patients.
    Ravi R; Haider G; Ahmed K; Zahoor S; Sami A; Lata R
    J Ayub Med Coll Abbottabad; 2020; 32(3):323-326. PubMed ID: 32829544
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Breast cancer prognosis in a mixed Caucasian-Hispanic population.
    Daly MB; Clark GM; McGuire WL
    J Natl Cancer Inst; 1985 Apr; 74(4):753-7. PubMed ID: 3857371
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis.
    Tong ZJ; Shi NY; Zhang ZJ; Yuan XD; Hong XM
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28667103
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Histopathologic characteristics predicting HER-2/neu amplification in breast cancer.
    Prati R; Apple SK; He J; Gornbein JA; Chang HR
    Breast J; 2005; 11(6):433-9. PubMed ID: 16297088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.